Pertussis vaccination for adolescents and adults

Bibliography

• HEININGER U: Pertussis: an old disease that is still with us. Carr: Opin. Infect. Dis. (2001) 14(3):329–333.
   PubMed Web of Science ®Google Scholar
• CAMPINS-MARTI M,MORAGA-LLOP FA: Acellular pertussisvaccines for use among infants and youngchildren. Expert Opin. Pliarinacether. (2004) 5(4):807–817.
   PubMed Web of Science ®Google Scholar
• •A comprehensive review concerning the efficacy, immunogenicity and safety of aP vaccine and its use in childhood.
   Google Scholar
• WORLD HEALTH ORGANIZATION:Pertussis vaccines — WHO position paper. Wkly Epideiniel. Rec. (1999) 74:137–144.
   PubMedGoogle Scholar
• ••World Health Organization position paperon the use of pertussis vaccines in the global context.
   Google Scholar
• YEH SH: Pertussis: persistent pathogen, imperfect vaccines. Expert Rev Vaccines (2003) 2(1):113–127.
   PubMedGoogle Scholar
• WORLD HEALTH ORGANIZATION, REGIONAL OFFICE FOR EUROPE:Strategy for pertussis prevention in the World Health Organization's European Region. Infect. Dis. (1996) 174\(Suppl. 3):S291–S294.
   Google Scholar
• KEITEL WA: Cellular and acellular pertussis vaccines in adults. Clin. Infect. Dis. (1999) 28\(Suppl. 2):S118–S13.
   Google Scholar
• KEITEL WA, MUENZ LR,DECKER MD et al.: A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization. Infect. Dis. (1999) 180:397–403.
   Google Scholar
• ROTHSTEIN EP, ANDERSON EL, DECKER MD et al.: An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric Associates. Vaccine (1999) 17:2999–3006.
   Google Scholar
• MINH NN, HE Q, RAMALHO A et al: Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents. Pediatrics (1999) 104(6):e70.
   PubMedGoogle Scholar
• HALPERIN SA, SMITH B, RUSSELL M et al.: An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine (2000) 18(4):1312–1319.
   PubMedGoogle Scholar
• HALPERIN SA, SMITH B, RUSSELL M et al.: Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr. Infect. Dis. J. (2000) 19(4):276–283.
   PubMed Web of Science ®Google Scholar
• VAN DAMME P, BURGESS M: Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults. Vaccine (2004) 22:305–308.
   PubMedGoogle Scholar
• GURIS D, STREBEL PM, BARDENHEIER B et al.: Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin. Infect. Dis. (1999) 28:1230–1237.
   PubMed Web of Science ®Google Scholar
• BLACKS: Epidemiology of pertussis. Pediatr. Infect. Dis. (1997) 16(4):585–589.
   Google Scholar
• HETHCOTE HW, HORBY P,MCINTYRE P: Using computer simulation to compare pertussis vaccination strategies in Australia. Vaccine (2004) 22:2181–2191.
   PubMed Web of Science ®Google Scholar
• OLIN P, GUSTAFSSON L, BARRETO L et al: Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine (2003) 21:2015–2021.
   PubMed Web of Science ®Google Scholar
• ORENSTEIN WA: Pertussis in adults: epidemiology, signs, symptoms, andimplications for vaccination. Clin. Infect.Dis. (1999) 28\(Supp1.2):S147–S150.
   Google Scholar
• NO AUTHORS LISTED: Pertussis - United States, 1997-2000. CDC. MMWR Morb. Mortal. Wkly Rep. (2002) 51:73–76.
   PubMedGoogle Scholar
• •CDC report summarising national surveillance data of pertussis in the US.
   Google Scholar
• YIH WK, LETT SM, DES VIGNES FN, GARRISON KM, SIPE PL,MARCHANT CD: The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989–1998.1 Infect. Dis. (2000) 182:1409–1416.
   Google Scholar
• SKOWRONSKI D, DE SERRES G, MACDONALD D et al.: The changing age and seasonal profile of pertussis in Canada. .1. Infect. Dis. (2002) 185:1448–1453.
   Google Scholar
• VAN BUYNDER PG, OWEN D, VURDIEN JE, ANDREWS NJ, MATTHEWS RC, MILLER E: Bordetella pertussis surveillance in England and Wales: 1995-97. Epideiniol Infect. (1999) 123:403–411.
   PubMed Web of Science ®Google Scholar
• MCINTYRE P, AMIN J, GIDDING H et al.: Vaccine preventable disease and vaccination coverage in Australia, 1993–1998. Commun. Dis. Intel] (2000) (Suppl.):22–26.
   Google Scholar
• BRENNAN M, STREBEL P, GEORGE H et al.: Evidence for transmission of pertussis in schools, Massachussets, 1996: epidemiologic data supported by pulsed field gel electroforesis studies. Infect. Dis (2000) 181:210–215.
   Google Scholar
• SRUGO I, BENILEVI D, MADEB R, SHAPIRO S et al.: Pertussis infection fully vaccinated children in day-care centers, Israel. Emerg. Infect. Dis. (2000) 6(5):526–529.
   PubMed Web of Science ®Google Scholar
• CORDOVA SP, GILLES MT, BEERS MY: The outbreak that had to happen: Bordetella pertussis in North West Australia in 1999. Commun. Dis. Intel] (2000) 24:375–379.
   PubMedGoogle Scholar
• NO AUTHORS LISTED: Pertussis outbreak among adults at an oil refinery-Illinois. MMWR Morb. Mortal. Wkly Rep. (2003) 52(1):1–4.
   Google Scholar
• NO AUTHORS LISTED: Transmission ofpertussis from adult to infant -- Michigan 1993. MMWR Morb. Mortal. Wkly Rep. (1995) 44(4):74–76.
   PubMedGoogle Scholar
• WIRSING VON KONIG CH, POSTELS-MULTANI S, BOCK HL, SCHMITT HJ: Pertussis in adults: frequency of transmission after household exposure. Lancet (1995) 346:1326–1329.
   PubMed Web of Science ®Google Scholar
• BARONS, NJAMKEPO E, GRIMPREL E et al.: Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr. Infect. Dis. (1998) 17(5):412–418.
   Google Scholar
• ELLIOTT E, MCINTYRE P, RIDLEY G et al.: National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr. Infect. Dis. j (2004) 23(3):246–252.
   PubMed Web of Science ®Google Scholar
• EVERETT S, HALLDORSON S, SAVOINI D et al.: School-associated pertussis outbreak -- Yavapai County, Arizona, September 2002 - February 2003. MMWR Morb. Mortal. Wkly Rep. (2004) 53(10216–219.
   Google Scholar
• WIRSING VON KONIG CH, HALPERIN S, RIFFELMANN M, GUISI N: Pertussis of adults and infants. Lancet Infect. Dis. (2002) 2:744–750.
   PubMed Web of Science ®Google Scholar
• ••An excellent review concerning pertussisepidemiology, clinical course andimplications for vaccination strategies.
   Google Scholar
• BIRKEB/EK NH, KRISTIANSEN M, SEEFELDT T et al: Bordetella pertussis and chronic cough in adults. Clin. Infect. Dis. (1999) 29:1239–1242.
   PubMed Web of Science ®Google Scholar
• GILBERG S, NJAMKEPO E, PARENT DU CHATELET I et al.: Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. Infect. Dis. (2002) 186:415–418.
   Google Scholar
• JACKSON LA, CHERRY JD, WANG S, GRAYSTON JT: Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in University students with cough illnesses. Clin. Infect. Dis. (2000) 31:3–6.
   PubMed Web of Science ®Google Scholar
• CHERRY JD: Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin. Infect. Dis. (1999) 28\(Supp1.2):S112–5117.
   Google Scholar
• •Paper investigating various aspects of pertussis in adults, considering the possibility of a booster immunisation programme.
   Google Scholar
• KONDA T, KAMACHI K, IWAKI M, MATSUNAGA Y: Distribution of pertussis antibodies among different age groups in Japan. Vaccine (2002) 20:1711–1717.
   Google Scholar
• DOMINGUEZ A, VIDAL J, PLANS P, SALLERAS L: The seroepidemiology of B. pertussis infection in Catalonia, Spain. Epidemio] Infect. (2001) 126:205–210.
   PubMed Web of Science ®Google Scholar
• GARCIA-CORBEIRA P, DAL-RE R, AGUILAR L, GARCIA DE LOMAS J: Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross sectional study. Vaccine (2000) 18:2173–2176.
   PubMed Web of Science ®Google Scholar
• ROTA MC, AUSIELLO CM,D'AMELIO R et al.: Prevalence of markers of exposure to Bordetella pertussis among Italian young adults. Clin. Infect. Dis. (1998) 26:297–302.
   Google Scholar
• HEININGER U, KLICH K, STEHR K, CHERRY JD: Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics (1997) 100 (6) :e10.
   PubMedGoogle Scholar
• YAARI E, YAFE-ZIMERMAN Y, SCHWARTZ SB et al.: Clinical manifestation of Bordetella pertussis infection in immunised children and young adults. Chest (1999) 115:1254–1258.
   PubMed Web of Science ®Google Scholar
• STORSAETER J, HALLANDER HO, GUSTAFSSON L, OLIN P: Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine (2003) 21:3542–3549.
   PubMed Web of Science ®Google Scholar
• SENZILET LD, HALPERIN SA, SPIKA JS et al: Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin. Infect. Dis. (2001) 32:1691–1697.
   PubMed Web of Science ®Google Scholar
• NO AUTHORS LISTED: Pertussis deaths - United States, 2000. MMWR Morb. Mortal. Wkly Rep. (2002) 51(28):616–618.
   PubMedGoogle Scholar
• GIL A, OYAGUEZ I, CARRASCO P, GONZALEZ A: Hospital admission for pertussis in Spain, 1995-1998. Vaccine (2001) 19:4791–4794.
   PubMed Web of Science ®Google Scholar
• MATTER HC: Pertussis surveillance in Switzerland, 1992 to 1997 - a large epidemic in 1994. What next?Euro Surveil]. (1999) 4(12):130–133.
   Google Scholar
• FUNG KS, YEUNG WL, WONG TW, SO KW, CHENG AF: Pertussis - a re-emerging infection?' Infect. (2004) 48:145–148.
   Google Scholar
• DE SERRES G, SHADMANI R, DUVAL B et al.: Morbidity of pertussis in adolescents and adults. Infect. Dis. (2000) 182:174–179.
   Web of Science ®Google Scholar
• •Study evaluating the effect of age on the clinical course of pertussis in adolescents and adults.
   Google Scholar
• NO AUTHORS LISTED: Fatal case of unsuspected pertussis diagnosed from a blood culture -- Minnesota, 2003. CDC.MMWR Morb. Mortal. Wkly Rep. (2004) 53(6):131–132.
   PubMedGoogle Scholar
• NIELSEN NM, HEDEGAARD K, AABY P: Intensity of exposure and severity of whooping cough. Infect. (2001) 43:177–181.
   Web of Science ®Google Scholar
• BRUSS JB, SIBER GR: Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model. Infect. Immun. (2002) 70(8):4600–4608.
   PubMed Web of Science ®Google Scholar
• BRUSS JB, MALLEY R, HALPERIN S et al: Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin. Pediatr. Infect. Dis. J. (1999) 18(6):505–511.
   PubMed Web of Science ®Google Scholar
• GRUBER MF: Maternal immunisation: US FDA regulatory considerations. Vaccine (2003) 21:3487–3491.
   PubMed Web of Science ®Google Scholar
• EDWARDS KM: Pertussis: an important target for maternal immunisation. Vaccine (2003) 21:3483–3486.
   PubMed Web of Science ®Google Scholar
• GARDNER P: Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal recommendations. Clin. Infect. Dis. (1999) 28\(Suppl. 2):5131–5135.
   Google Scholar
• CAMPINS-MARTI M, CHENG HK, FORSYTH K et al.: Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine (2001) 20:641–646.
   PubMedGoogle Scholar
• •Paper considering the different immunisation strategies for older age groups.
   Google Scholar
• D'ANGELO LJ, MAGNUS MD: The changing epidemiology of pertussis: should we adopt a vaccine policy for adolescents? Adolesc. Health. (2004) 34(2):119–120.
   Web of Science ®Google Scholar
• NO AUTHORS LISTED: National consensus conference on pertussis, Toronto, may 25–28, 2002. Can. Commun. Dis. Rep. (2003) 29 (Supp1.3) :1–33.
   Google Scholar
• •State of the art on clinical, diagnostic, epidemiological and preventive aspects of B. pertussis infection.
   Google Scholar
• HEWLETT EL, HALPERIN SA: Serological correlates of immunity to Bordetella pertussis. Vaccine (1998) 16(20):1899–1900.
   PubMed Web of Science ®Google Scholar
• TROLLFORS B, LAGERGARD T, GUNNARSSON E, TARANGER J: Determination of pertactin IgG antibodies for the diagnosis of pertussis. Clin. Microbiol Infect. (2003) 9(7):585–589.
   PubMed Web of Science ®Google Scholar
• DE MELKER HE, SCHELLEKENS JF, NEPPELENBROEK SE et al.:Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg. Infect. Dis. (2000) 6(4):348–357.
   PubMed Web of Science ®Google Scholar
• VAN BOVEN M, DE MELKER HE, SCHELLEKENS JF, KRETZSCHMAR M: A model based evaluation of the 1996-7 pertussis epidemic in the Netherlands. Epidemiol Infect. (2001) 127:73–85.
   PubMed Web of Science ®Google Scholar
• MOOI FR, VAN OIRSCHOT H, HEUVELMAN K,VAN DER HEIDE HG, GAASTRA W, WILLEMS RJ: Polymorphism in the Bordetella pertussis virulence factors P69/ pertactin and pertussis toxin in the Netherlands: temporal trends and evidence of vaccine-driven evolution. Infect. Immun. (1998) 66:670–675.
   PubMed Web of Science ®Google Scholar
• MOOI FR, HE Q, VAN OIRSCHOT H, MERTSOLA J: Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect. Immun. (1999) 67:3133–3134.
   PubMed Web of Science ®Google Scholar
• MASTRANTONIO P, SPIGAGLIA P, VAN OIRSCHOT H et al.: Antigenic variants in Bordetella pertussisstrains isolated from vaccinated and unvaccinated children. Microbiology (1999) 45:2069–2075.
   Google Scholar
• DECRETO DEL PRESIDENTE DELLA REPUBBLICA: 7 novembre 2001, n.464. Regolamento recante modalità di esecuzione delle rivaccinazioni antitetaniche, a norma dell'articolo 93, comma 2, della legge 23 dicembre 2000, n.388.
   Google Scholar
• PICHICHERO ME, TREANOR J: Economic impact of pertussis. Arch. Pediatr. Adolesc. Med. (1997) 151(1):35–40.
   PubMed Web of Science ®Google Scholar
• EDMUNDS WJ, BRISSON M, MELEGARO A, GAY NJ: The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine (2002) 20:1316–1330.
   PubMed Web of Science ®Google Scholar
• http://www.ministerosalute.it/promozione/ malattie/bollettinajspMinistero della Salute, epidemiological research.
   Google Scholar
• http://www.epicentro.iss.it/archivio/ 192004/ 19-2-2004/abs%20pertosse.pdfCUCCIA M, CUTULI D: Epidemia dipertosse-provincia di Catania (2002).
   Google Scholar
• http://www.invs.sante.fr/beh/ 192002/06/ Bulletin épidémiologique hebdomadaire, calendrier vaccinal 2000.
   Google Scholar
• http://www.rki.de/INFEKT/EPIBULL/ 192003/32_03.PDFRobert Koch Institute, epidemiologisches bulletin.
   Google Scholar
• http://www.cdc.goidnip/recs/adult-schedule.htmCDC National Immunization Program, recommendations: adult immunization schedule.
   Google Scholar